ZGNX - Lawsuit for Investors in Zogenix Inc. (NASDAQ: ZGNX) shares announced by Shareholders Foundation

SAN DIEGO, CA / ACCESSWIRE / May 7, 2019 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Zogenix, Inc. (NASDAQ: ZGNX) shares.

Investors, who purchased shares of Zogenix, Inc. (NASDAQ: ZGNX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges that the defendants made false and/or misleading statements and/or failed to disclose that Zogenix's NDA for FINTEPLA contained inadequate non-clinical data and an incorrect version of a clinical dataset, that consequently, Zogenix's NDA for FINTEPLA was unlikely to gain FDA approval, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased Zogenix, Inc. (NASDAQ: ZGNX) shares should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

SOURCE: Shareholders Foundation, Inc.